Arca
Skip to content
Tools
Tools

Ischemic optic neuropathy

Drug research and approvals for ischemic optic neuropathy: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 14 studies of ischemic optic neuropathy are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 4 open orphan designations naming it.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 14 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 3

Phase 2 3

Phase 1 or earlier 4

How its trials ended

46 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 7 whose ending is known, 43% met their primary endpoint, 0% missed it and 57% stopped early.

  • Completed, result not reported2043%
  • Status unknown1124%
  • Ongoing817%
  • Met its primary endpoint37%
  • Stopped: other or unclear24%
  • Stopped: enrollment or feasibility12%
  • Stopped: sponsor or business decision12%

FDA orphan designations

Approved first, then open designations, newest first
Jul 26, 202119 amino acid synthetic peptide NOS-enhancerTreatment of anterior ischemic optic neuropathyBiozeus Biopharmaceutical SADesignated
Dec 26, 2017NP-CSIC002Treatment of anterior ischemic optic neuropathy (AION)Neurizon PharmaDesignated
Sep 25, 2012Synthetic double-stranded siRNA oligonucleotide directed…Treatment of ischemic optic neuropathyQuark Pharmaceuticals, Inc.Designated
Feb 7, 2000BrimonidineTreatment of anterior ischemic optic neuropathy.AbbVieDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.